Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice.

Obesity/metabolic syndrome are common risk factors for overactive bladder. This study aimed to investigate the functional and molecular changes of detrusor smooth muscle (DSM) in high-fat insulin resistant obese mice, focusing on the role of protein kinase C (PKC) and Ca(v)1.2 in causing bladder dys...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Luiz O Leiria, Carolina Sollon, Marina C Calixto, Letícia Lintomen, Fabíola Z Mónica, Gabriel F Anhê, Gilberto De Nucci, Angelina Zanesco, Andrew D Grant, Edson Antunes
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3fd31b1e20ca40359c22230386b9b370
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3fd31b1e20ca40359c22230386b9b370
record_format dspace
spelling oai:doaj.org-article:3fd31b1e20ca40359c22230386b9b3702021-11-18T08:09:45ZRole of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice.1932-620310.1371/journal.pone.0048507https://doaj.org/article/3fd31b1e20ca40359c22230386b9b3702012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23144896/?tool=EBIhttps://doaj.org/toc/1932-6203Obesity/metabolic syndrome are common risk factors for overactive bladder. This study aimed to investigate the functional and molecular changes of detrusor smooth muscle (DSM) in high-fat insulin resistant obese mice, focusing on the role of protein kinase C (PKC) and Ca(v)1.2 in causing bladder dysfunction. Male C57BL/6 mice were fed with high-fat diet for 10 weeks. In vitro functional responses and cystometry, as well as PKC and Ca(v)1.2 expression in bladder were evaluated. Obese mice exhibited higher body weight, epididymal fat mass, fasting glucose and insulin resistance. Carbachol (0.001-100 µM), α,β-methylene ATP (1-10 µM), KCl (1-300 mM), extracellular Ca(2+) (0.01-100 mM) and phorbol-12,13-dibutyrate (PDBu; 0.001-3 µM) all produced greater DSM contractions in obese mice, which were fully reversed by the Ca(v)1.2 blocker amlodipine. Cystometry evidenced augmented frequency, non-void contractions and post-void pressure in obese mice that were also prevented by amlodipine. Metformin treatment improved the insulin sensitivity, and normalized the in vitro bladder hypercontractility and cystometric dysfunction in obese mice. The PKC inhibitor GF109203X (1 µM) also reduced the carbachol induced contractions. PKC protein expression was markedly higher in bladder tissues from obese mice, which was normalized by metformin treatment. The Ca(v)1.2 channel protein expression was not modified in any experimental group. Our findings show that Ca(v)1.2 blockade and improvement of insulin sensitization restores the enhanced PKC protein expression in bladder tissues and normalizes the overactive detrusor. It is likely that insulin resistance importantly contributes for the pathophysiology of this urological disorder in obese mice.Luiz O LeiriaCarolina SollonMarina C CalixtoLetícia LintomenFabíola Z MónicaGabriel F AnhêGilberto De NucciAngelina ZanescoAndrew D GrantEdson AntunesPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 11, p e48507 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Luiz O Leiria
Carolina Sollon
Marina C Calixto
Letícia Lintomen
Fabíola Z Mónica
Gabriel F Anhê
Gilberto De Nucci
Angelina Zanesco
Andrew D Grant
Edson Antunes
Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice.
description Obesity/metabolic syndrome are common risk factors for overactive bladder. This study aimed to investigate the functional and molecular changes of detrusor smooth muscle (DSM) in high-fat insulin resistant obese mice, focusing on the role of protein kinase C (PKC) and Ca(v)1.2 in causing bladder dysfunction. Male C57BL/6 mice were fed with high-fat diet for 10 weeks. In vitro functional responses and cystometry, as well as PKC and Ca(v)1.2 expression in bladder were evaluated. Obese mice exhibited higher body weight, epididymal fat mass, fasting glucose and insulin resistance. Carbachol (0.001-100 µM), α,β-methylene ATP (1-10 µM), KCl (1-300 mM), extracellular Ca(2+) (0.01-100 mM) and phorbol-12,13-dibutyrate (PDBu; 0.001-3 µM) all produced greater DSM contractions in obese mice, which were fully reversed by the Ca(v)1.2 blocker amlodipine. Cystometry evidenced augmented frequency, non-void contractions and post-void pressure in obese mice that were also prevented by amlodipine. Metformin treatment improved the insulin sensitivity, and normalized the in vitro bladder hypercontractility and cystometric dysfunction in obese mice. The PKC inhibitor GF109203X (1 µM) also reduced the carbachol induced contractions. PKC protein expression was markedly higher in bladder tissues from obese mice, which was normalized by metformin treatment. The Ca(v)1.2 channel protein expression was not modified in any experimental group. Our findings show that Ca(v)1.2 blockade and improvement of insulin sensitization restores the enhanced PKC protein expression in bladder tissues and normalizes the overactive detrusor. It is likely that insulin resistance importantly contributes for the pathophysiology of this urological disorder in obese mice.
format article
author Luiz O Leiria
Carolina Sollon
Marina C Calixto
Letícia Lintomen
Fabíola Z Mónica
Gabriel F Anhê
Gilberto De Nucci
Angelina Zanesco
Andrew D Grant
Edson Antunes
author_facet Luiz O Leiria
Carolina Sollon
Marina C Calixto
Letícia Lintomen
Fabíola Z Mónica
Gabriel F Anhê
Gilberto De Nucci
Angelina Zanesco
Andrew D Grant
Edson Antunes
author_sort Luiz O Leiria
title Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice.
title_short Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice.
title_full Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice.
title_fullStr Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice.
title_full_unstemmed Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice.
title_sort role of pkc and cav1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/3fd31b1e20ca40359c22230386b9b370
work_keys_str_mv AT luizoleiria roleofpkcandcav12indetrusoroveractivityinamodelofobesityassociatedwithinsulinresistanceinmice
AT carolinasollon roleofpkcandcav12indetrusoroveractivityinamodelofobesityassociatedwithinsulinresistanceinmice
AT marinaccalixto roleofpkcandcav12indetrusoroveractivityinamodelofobesityassociatedwithinsulinresistanceinmice
AT leticialintomen roleofpkcandcav12indetrusoroveractivityinamodelofobesityassociatedwithinsulinresistanceinmice
AT fabiolazmonica roleofpkcandcav12indetrusoroveractivityinamodelofobesityassociatedwithinsulinresistanceinmice
AT gabrielfanhe roleofpkcandcav12indetrusoroveractivityinamodelofobesityassociatedwithinsulinresistanceinmice
AT gilbertodenucci roleofpkcandcav12indetrusoroveractivityinamodelofobesityassociatedwithinsulinresistanceinmice
AT angelinazanesco roleofpkcandcav12indetrusoroveractivityinamodelofobesityassociatedwithinsulinresistanceinmice
AT andrewdgrant roleofpkcandcav12indetrusoroveractivityinamodelofobesityassociatedwithinsulinresistanceinmice
AT edsonantunes roleofpkcandcav12indetrusoroveractivityinamodelofobesityassociatedwithinsulinresistanceinmice
_version_ 1718422100961656832